USD 3.66 billion
Report ID:
SQMIG35A2194 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
143
|Figures:
77
Global Smart Insulin Pens Market size was valued at USD 3.66 billion in 2022 and is expected to rise from USD 4.03 billion in 2023 to reach a value of USD 8.63 billion by 2031, at a CAGR of 10% during the forecast period (2024–2031).
Smart insulin pens are a better solution for diabetes management because they help in external administration of insulin to diabetic patients. The smart insulin pens are designed in such a manner that they aid in the administration of doses on a regular basis as a result of the system's timely reminders and alerts. Owing to their ease of use, smart insulin pens are becoming increasingly popular. The smart device can be attached to an existing insulin pen of a diabetic patient. The market for smart insulin pens is expanding due to the ability to provide timely alerts or periodic reminders, which aids in providing the correct insulin dosage. It also aids in monitoring any missed doses, which is critical for diabetic patients. This smart insulin pen has provided a very convenient solution for the management of type 1 and type 2 diabetes. Maintaining a record of the patient's diabetes profile by monitoring the diabetes levels at a specific time and date, as well as the sequential order is crucial. The smart insulin pen is an expert at determining the temperature range of the insulin dose and moreover keeps a close eye on the expiry date of the medicine to ensure the safety of patients from health hazards. The COVID-19 pandemic had a significant negative impact on the smart insulin pen market, thereby, restricting growth. The government's strict lockdown and restrictions, as well as restricted movement, had kept people at home, preventing laboratory testing and resulting in unchecked diabetes profiles. As a result, the medical sector's diabetic services were severely hampered.
US Smart Insulin Pens Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 3.66 billion
Largest Segment
Home Care Settings
Fastest Growth
Hospitals & clinics
Growth Rate
10% CAGR
To get more reports on the above market click here to Buy The Report
The global smart insulin pens market is segmented based on product, connectivity type, indication, end-user, and region. Based on product, the smart insulin pens market is segmented into smart insulin pens, and adaptors for conventional pens. In terms of segmentation by connectivity type, the Smart Insulin Pens Market is segmented into Bluetooth, and USB. With respect to indication, the Smart Insulin Pens Market is segmented into type 1 diabetes, type 2 Diabetes. The end-user segment is further classified into hospitals & clinics, ambulatory surgical centers, and home care settings. Based on region, Smart Insulin Pens Market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Smart Insulin Pens Market Analysis by End-user
Based on end-users, the smart insulin pens market is segmented into hospitals & clinics, ambulatory surgical centers, and home care settings. The hospitals & clinics segment is expected to earn the largest market share in managing diabetes and its complications during the forecast period. These sub-segments provide highly skilled workers and personnel who are experienced in dealing with and managing these types of cases. In order to provide error-less services to patients, hospitals prioritise their patient’s safety. Smart insulin pens are progressively being used by the healthcare industry to manage blood sugar in the most simple and convenient ways possible.
The ambulatory surgical centres segment is expected to grow moderately during the forecast period because it includes advanced facilities for providing first-rate care to patients. This sector is focusing on implementing cutting-edge technology in order to provide the best medical services possible to patients in the absence of a proper hospital or clinic at the time.
The home care settings segment is expected to register the fastest growth rate in the forecast period. This is owing to the presence of a large number of geriatric population worldwide, there has been a new scope of market growth. People in their old age prefer to aid medical services within the comfort of their homes or familiar surroundings. These include diabetes-check-ups, blood sample collection for tests, and home care settings. Among these, the home care settings segment has proven to be extremely beneficial to the smart insulin pen market growth. As a result, the aged people rely more on home kits to monitor their blood sugar levels, thereby creating new business generation opportunities for this future market.
Smart Insulin Pens Market Analysis by indication
Based on indication, the smart insulin pens market is segmented into type 1 diabetes, type 2 diabetes. Owing to the high prevalence of diabetes across all age groups, type 2 diabetes treatment is supposed to generate considerable revenue streams during the forecast years. Smart insulin pens have helped to transform diabetic care by adapting in a connected care ecosystem for patients, providers, and health systems.
To get detailed analysis on other segments, Request For Free Sample Report
Demographically, the global smart insulin pens market is widespread into the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these, every region is further classified based on the key countries contributing to the market growth. The rise in prevalence of diabetes in countries such as Canada and the US augments the cost of smart insulin pumps in North America, thus, helping it contribute the largest share in 2021 and to continue so in the forecast period. In addition to this, the presence of multiple players in this region, coupled with the high rate of technological adoption is also driving the North America smart insulin pens market. Furthermore, the market in North America is expected to be driven by new product launches and related FDA approvals.
Diabetes affected approximately 537 million adults aged 20 to 79 in 2021. The total number of diabetics is expected to rise to 643 million by 2030 and 783 million by 2045. According to the American Diabetes Association (ADA), over a million new cases of diabetes are diagnosed in the United States each year. The Center for Disease Control and Prevention (CDC) is actively working to start reversing this epidemic by assisting in the identification of people with prediabetes, the prevention of type 2 diabetes and its complications, and the improvement of overall health. The American Diabetes Association (ADA) revised its diabetes guidelines in 2022. The ADA recommended the use of insulin pens rather than vials and syringes for the first time. Smart insulin pens, for example, are most likely to have an impact in better diabetes management compared to the traditional methods.
The Europe market is projected to emerge as the fastest growing market during the forecast period. As the trend toward non-invasive surgeries continues, healthcare providers across the UK are emphasizing on the importance of needle-free insulin injections. These injections reduce the discomfort and trauma of the patient associated with needle insertion. As a result, smart insulin pens that incorporate a variety of modern techniques are gaining traction, thus, driving the European market during the forecast period.
As a result of the new facilities made available to the people, the MEA region is expected to grow at the fastest rate during the forecast period.
The Asia Pacific region may also register significant growth in this sector as a result of the increasing number of diabetic patients in developing countries such as China, India, and others.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Smart Insulin Pens Market Driver
Busy Lifestyles and Tight Daily Schedules Augments Need for Insulin Dose Trackers
Smart Insulin Pens Market Restraint
High Cost of Smart Insulin Pens may Hinder Growth
Request Free Customization of this report to help us to meet your business objectives.
The global smart insulin pens market is highly competitive and somewhat fragmented in nature. To maintain a competitive edge, major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.
Smart Insulin Pens Market Top Player's Company Profiles
Sanofi S.A.
Companion Medical Inc.
Diabnext
Insulet Corporation
Pendiq GmbH
Digital Medics Pty Ltd.
F. Hoffmann-La Roche AG
Ypsomed AG
Common Sensing Inc.
InjexUK Ltd.
Diamesco Co., Ltd.
Nipro Corporation
Jiangsu Delfu Co., Ltd.
Wockhardt Ltd.
Biocon Ltd.
Smart Insulin Pens Market Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global smart insulin pens market analysis, in Asia Pacific, the smart insulin pens market is projected to grow gradually over the projected time frame, owing to an older population that is more susceptible to being diagnosed with diabetes. Smart insulin pens are in great supply worldwide, owing to an increase in diabetes cases caused by obesity, unhealthy lifestyles, and old age. However, a restriction on using all types of insulin through a pen, such as mixing different types in one injection, is a limiting factor in the market for smart insulin pens.
What's Included
NA
Report Metric | Details |
---|---|
Market size value in 2023 | USD 3.66 billion |
Market size value in 2031 | USD 8.63 billion |
Growth Rate | 10% |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Smart Insulin Pens Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Smart Insulin Pens Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Smart Insulin Pens Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Smart Insulin Pens Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2194
sales@skyquestt.com
USA +1 351-333-4748